{
    "2019-11-04": [
        [
            {
                "time": "2019-11-02",
                "original_text": "医药板块2019Q3分析暨11月月报：三季报期总结：结构性高增长持续，建议继续重点布局高景气板块",
                "features": {
                    "keywords": [
                        "医药",
                        "高增长",
                        "三季报",
                        "高景气板块"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-02",
                "original_text": "医疗保健：短期看医保谈判 荐11股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "医保谈判",
                        "荐股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-02",
                "original_text": "医药股核心资产集体新高 四大资金狂扫货 这些股目标涨幅30%以上",
                "features": {
                    "keywords": [
                        "医药股",
                        "核心资产",
                        "资金流入",
                        "目标涨幅"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-02",
                "original_text": "【民生医药|跟踪点评】泰格医药：临床前业务布局加速，值得重点关注",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "临床前业务",
                        "布局加速"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-11-02",
                "original_text": "医药新股周期 筛选六大细分行业长跑冠军（附表）",
                "features": {
                    "keywords": [
                        "医药",
                        "细分行业",
                        "长跑冠军"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}